A Study of RAY1225 in Participants With Impaired Kidney Function

Clinical trial NCT06613763 · COMPLETED

Trial details

NCT number: NCT06613763
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Impairment

Start date: 2024-09-11
Primary completion: 2025-01-10
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.